Drug development – Page 29

ADME liabilities identified late during regulatory interaction preparation – how to avoid late-stage attrition

Addressing Late Identification of ADME Liabilities During Regulatory Preparations In the landscape of pharmaceutical drug development, the late identification of ADME (Absorption, Distribution, Metabolism, and Excretion) liabilities can lead to…

Poor hit-to-lead progression during early discovery – risk mitigation strategy

“`html Strategic Investigation into Poor Hit-to-Lead Progression During Early Discovery In the highly competitive realm of pharmaceutical research and drug development, the ability to swiftly and effectively advance compounds from…

R&D Bottlenecks and Scale-Up Failures? End-to-End Drug Development Solutions That Work

Overcoming R&D Bottlenecks and Scale-Up Failures in Pharmaceutical Development In the dynamic landscape of pharmaceutical research and drug development, R&D bottlenecks and scale-up failures can significantly impede progress, causing delays…

Managing Heat Sensitivity of APIs During Fluid Bed Granulation Equipment Validation

Managing Heat Sensitivity of APIs During Fluid Bed Granulation Equipment Validation Managing Heat Sensitivity of APIs During Fluid Bed Granulation Equipment Validation Introduction: The pharmaceutical industry is constantly evolving with…

Resolving Layer Separation in Bilayer Tablets During Long-Term Stability Testing

Resolving Layer Separation in Bilayer Tablets During Long-Term Stability Testing Resolving Layer Separation in Bilayer Tablets During Long-Term Stability Testing Introduction: Bilayer tablets have emerged as a versatile and efficient…

Addressing Root Cause Analysis for Coating Defects in Sustained Release Tablets

Addressing Root Cause Analysis for Coating Defects in Sustained Release Tablets Addressing Root Cause Analysis for Coating Defects in Sustained Release Tablets Introduction: In the pharmaceutical industry, ensuring the quality…

Investigating Variability in Hardness Retention During Stability Studies

Investigating Variability in Hardness Retention During Stability Studies Investigating Variability in Hardness Retention During Stability Studies Introduction: In the pharmaceutical industry, ensuring the stability of drug products is paramount to…

Troubleshooting Heat Sensitivity Issues in APIs During Validation Testing

Troubleshooting Heat Sensitivity Issues in APIs During Validation Testing Troubleshooting Heat Sensitivity Issues in APIs During Validation Testing Introduction: In the pharmaceutical industry, ensuring the stability and efficacy of Active…

Ensuring Adequacy of Process Validation for Sugar-Coated Tablets

Ensuring Adequacy of Process Validation for Sugar-Coated Tablets Ensuring Adequacy of Process Validation for Sugar-Coated Tablets Introduction: Process validation is a critical aspect of pharmaceutical manufacturing, ensuring that products consistently…

Managing API Instability in Multi-API Tablets During Long-Term Storage

Managing API Instability in Multi-API Tablets During Long-Term Storage Managing API Instability in Multi-API Tablets During Long-Term Storage Introduction: In the dynamic field of pharmaceuticals, the development of multi-active pharmaceutical…

Ensuring Robustness in API Distribution in Multi-API Tablet Validation

Ensuring Robustness in API Distribution in Multi-API Tablet Validation Ensuring Robustness in API Distribution in Multi-API Tablet Validation Introduction: In the pharmaceutical industry, the development of multi-API (Active Pharmaceutical Ingredient)…

Troubleshooting Adhesion Failures in Enteric-Coated Tablet Layers

Troubleshooting Adhesion Failures in Enteric-Coated Tablet Layers Troubleshooting Adhesion Failures in Enteric-Coated Tablet Layers Introduction: Enteric-coated tablets are essential in pharmaceutical formulation, providing targeted drug delivery by ensuring that the…